tiprankstipranks
Trending News
More News >
Community Health Systems (DE:CG5)
NYSE:CG5
Germany Market

Community Health (CG5) Ratios

Compare
1 Followers

Community Health Ratios

DE:CG5's free cash flow for Q4 2025 was $-1.35. For the 2025 fiscal year, DE:CG5's free cash flow was decreased by $ and operating cash flow was $0.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.46 1.46 1.41 1.50 1.41
Quick Ratio
1.46 1.46 1.27 1.34 1.25
Cash Ratio
0.12 0.12 0.02 0.02 0.05
Solvency Ratio
0.07 0.07 >-0.01 0.02 0.03
Operating Cash Flow Ratio
0.25 0.25 0.20 0.10 0.14
Short-Term Operating Cash Flow Coverage
4.31 4.31 3.56 1.45 1.78
Net Current Asset Value
$ -10.81B$ -10.81B$ -12.07B$ -12.07B$ -12.32B
Leverage Ratios
Debt-to-Assets Ratio
0.88 0.88 0.86 0.84 0.84
Debt-to-Equity Ratio
-8.31 -8.31 -6.32 -8.75 -9.06
Debt-to-Capital Ratio
1.14 1.14 1.19 1.13 1.12
Long-Term Debt-to-Capital Ratio
1.15 1.15 1.21 1.14 1.14
Financial Leverage Ratio
-9.47 -9.47 -7.34 -10.38 -10.73
Debt Service Coverage Ratio
1.57 1.98 1.17 1.13 0.97
Interest Coverage Ratio
-11.40 -11.40 0.63 1.15 0.96
Debt to Market Cap
26.07 25.93 28.80 27.93 20.78
Interest Debt Per Share
92.91 92.91 98.14 99.75 102.83
Net Debt to EBITDA
7.01 5.60 9.66 9.37 10.51
Profitability Margins
Gross Profit Margin
8.67%8.67%41.71%40.69%40.18%
EBIT Margin
9.52%12.77%6.67%6.97%5.89%
EBITDA Margin
12.94%16.18%9.89%10.37%9.57%
Operating Profit Margin
-79.42%-79.42%4.29%7.66%6.72%
Pretax Profit Margin
5.80%5.80%-2.24%1.66%2.86%
Net Profit Margin
4.08%4.08%-4.08%-1.06%0.38%
Continuous Operations Profit Margin
5.41%5.41%-2.87%0.13%1.47%
Net Income Per EBT
70.30%70.30%182.33%-64.25%13.18%
EBT Per EBIT
-7.30%-7.30%-52.21%21.63%42.51%
Return on Assets (ROA)
3.85%3.85%-3.67%-0.92%0.31%
Return on Equity (ROE)
-31.57%-36.51%26.96%9.55%-3.37%
Return on Capital Employed (ROCE)
-90.17%-90.17%4.63%7.77%6.58%
Return on Invested Capital (ROIC)
-83.24%-83.24%4.58%0.59%3.33%
Return on Tangible Assets
5.15%5.22%-5.11%-1.29%0.45%
Earnings Yield
126.62%121.75%-130.64%-32.59%8.27%
Efficiency Ratios
Receivables Turnover
6.01 6.01 5.16 5.29 5.71
Payables Turnover
13.54 13.54 9.39 9.13 10.65
Inventory Turnover
0.00 0.00 22.25 22.59 20.69
Fixed Asset Turnover
1.40 2.44 2.34 2.13 2.00
Asset Turnover
0.95 0.95 0.90 0.86 0.83
Working Capital Turnover Ratio
12.20 12.60 12.50 12.73 12.14
Cash Conversion Cycle
33.77 33.77 48.24 45.20 47.24
Days of Sales Outstanding
60.72 60.72 70.69 69.00 63.88
Days of Inventory Outstanding
0.00 0.00 16.41 16.16 17.64
Days of Payables Outstanding
26.95 26.95 38.86 39.96 34.28
Operating Cycle
60.72 60.72 87.10 85.16 81.52
Cash Flow Ratios
Operating Cash Flow Per Share
4.05 4.05 3.63 1.61 2.33
Free Cash Flow Per Share
1.55 1.55 0.91 -1.97 -0.89
CapEx Per Share
2.50 2.50 2.73 3.58 3.22
Free Cash Flow to Operating Cash Flow
0.38 0.38 0.25 -1.22 -0.38
Dividend Paid and CapEx Coverage Ratio
1.62 1.62 1.33 0.45 0.72
Capital Expenditure Coverage Ratio
1.62 1.62 1.33 0.45 0.72
Operating Cash Flow Coverage Ratio
0.05 0.05 0.04 0.02 0.02
Operating Cash Flow to Sales Ratio
0.04 0.04 0.04 0.02 0.02
Free Cash Flow Yield
50.01%49.75%30.38%-62.97%-20.67%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
0.79 0.82 -0.77 -3.07 12.10
Price-to-Sales (P/S) Ratio
0.03 0.03 0.03 0.03 0.05
Price-to-Book (P/B) Ratio
-0.29 -0.30 -0.21 -0.29 -0.41
Price-to-Free Cash Flow (P/FCF) Ratio
2.00 2.01 3.29 -1.59 -4.84
Price-to-Operating Cash Flow Ratio
0.74 0.77 0.82 1.94 1.85
Price-to-Earnings Growth (PEG) Ratio
0.01 >-0.01 >-0.01 <0.01 -0.15
Price-to-Fair Value
-0.29 -0.30 -0.21 -0.29 -0.41
Enterprise Value Multiple
7.27 5.81 9.98 9.69 10.98
Enterprise Value
11.74B 11.74B 12.46B 12.54B 12.83B
EV to EBITDA
7.27 5.81 9.98 9.69 10.98
EV to Sales
0.94 0.94 0.99 1.00 1.05
EV to Free Cash Flow
56.42 56.43 103.83 -48.81 -111.53
EV to Operating Cash Flow
21.61 21.62 25.96 59.73 42.75
Tangible Book Value Per Share
-30.99 -32.07 -39.95 -38.25 -39.78
Shareholders’ Equity Per Share
-10.40 -10.40 -14.49 -10.68 -10.61
Tax and Other Ratios
Effective Tax Rate
0.07 0.07 -0.28 0.92 0.49
Revenue Per Share
93.17 93.17 95.64 95.79 94.80
Net Income Per Share
3.80 3.80 -3.91 -1.02 0.36
Tax Burden
0.70 0.70 1.82 -0.64 0.13
Interest Burden
0.61 0.45 -0.34 0.24 0.49
Research & Development to Revenue
0.00 0.00 0.00 <0.01 <0.01
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 <0.01 0.00 0.00 0.00
Income Quality
1.07 0.80 -0.93 -1.58 6.52
Currency in USD